negotiable 发表于 2025-3-23 10:11:32

http://reply.papertrans.cn/3/261/26074/26074-11.png

少量 发表于 2025-3-23 17:03:44

Submitted on: 10 September 2013.
Revised on: 01 October 2013.
Accepted on: 25 October 2013.
RADIOTHERAPY AND ONCOLOGY---ELSEVIER IRELAND LTD

cumber 发表于 2025-3-23 19:44:10

Submitted on: 05 January 2003.
Revised on: 06 February 2003.
Accepted on: 14 February 2003.
RADIOTHERAPY AND ONCOLOGY

体贴 发表于 2025-3-23 22:43:06

http://reply.papertrans.cn/3/261/26074/26074-14.png

假 发表于 2025-3-24 05:18:49

Submitted on: 29 October 2012.
Revised on: 19 November 2012.
Accepted on: 27 November 2012.
RADIOTHERAPY AND ONCOLOGY---ELSEVIER IRELAND LTD

忍受 发表于 2025-3-24 08:21:50

http://reply.papertrans.cn/3/261/26074/26074-16.png

hypnotic 发表于 2025-3-24 12:16:27

http://reply.papertrans.cn/3/261/26074/26074-17.png

乐意 发表于 2025-3-24 15:46:30

Submitted on: 26 December 2003.
Revised on: 04 January 2004.
Accepted on: 18 January 2004.
RADIOTHERAPY AND ONCOLOGY---ELSEVIER IRELAND LTD

altruism 发表于 2025-3-24 20:26:13

Submitted on: 05 June 2002.
Revised on: 21 June 2002.
Accepted on: 28 June 2002.
RADIOTHERAPY AND ONCOLOGY

recede 发表于 2025-3-25 03:12:20

Submitted on: 05 July 2001.
Revised on: 30 July 2001.
Accepted on: 05 August 2001.
RADIOTHERAPY AND ONCOLOGY---ELSEVIER IRELAND LTD
页: 1 [2] 3 4
查看完整版本: SCIE期刊RADIOTHERAPY AND ONCOLOGY 2024/2025影响因子:4.958 (RADIOTHER ONCOL) (0167-8140). (ONCOLOGY)(肿瘤学)Science Citation Inde